Pharmacytimes: Condition Center: Mental Health Mental Health en-us Mon, 23 Jul 2018 11:46:19 UTC Mon, 23 Jul 2018 11:46:19 UTC Fluoroquinolone Warnings for Mental Health, Hypoglycemia Risks are Updated Officials with the FDA are requiring safety label updates for fluoroquinolone antibiotics due to risks of mental health adverse effects, and blood sugar disturbances. 11:00 AM, Wed July 11, 2018 Schizophrenia Regimen Approved by FDA Officials with the FDA have approved an Alkermes aripiprazole lauroxil (Aristada Initio) extended-release product for the treatment of schizophrenia in adults, according to the company. 5:18 PM, Mon July 2, 2018 5 Ways Pharmacists Can Help Prevent Suicide The deaths this week of Kate Spade and&nbsp;Anthony Bourdain have sparked a much-needed public discussion about mental health and suicide can be prevented. 2:00 PM, Fri June 8, 2018 A Video Game to Create Empathy This adult fantasy game provides a first-hand view of psychosis and the symptoms its patients often experience. 12:59 AM, Thu May 10, 2018 Dextromethorphan Studied for Use In Bipolar Disorder Dextromethorphan neuroprotective characteristics may play a role in patients with bipolar disorder. 12:23 PM, Tue May 8, 2018 ASD and Medication Adherence: An Opportunity for Pharmacist Intervention Unfortunately, medication adherence in children with ASD is poor, particularly among children with chronic conditions or comorbid mental health conditions. 1:43 AM, Wed March 14, 2018 FDA OKs Lurasidone for Use as Bipolar Medication in Children Officials with the FDA have approved a supplemental new drug application (sNDA) to expand the use of lurasidone HCl (Latuda, Sunovion) to include the treatment of bipolar depression in pediatric patients (10 to 17 years of age). 7:00 AM, Wed March 7, 2018 The Science Behind Pharmacist Burnout Is Scary: Here Is What to Do About It Experts are finding, though, that burnout doesn&#39;t limit its impact to the workplace. It also impacts parts of your life that extend well beyond the pharmacy. 10:24 PM, Wed January 24, 2018 The Proven Health Benefits of Yoga and Meditation Discover how a mindfulness practice can improve a person&#39;s quality of life. 10:00 AM, Sat January 20, 2018 Allergan, Gedeon Richter Plan to Submit Cariprazine sNDA for Depression Officials with Allergan and Gedeon Richter are reporting positive topline results for a phase 3 study of cariprazine (Vraylar) for the treatment of adults with bipolar I depression.<br /> &nbsp; 2:00 AM, Wed December 20, 2017 Perinatal HIV Infection: Nonadherence Risk Increases in Adolescents Adolescents and young adults who are living with HIV and were exposed to the virus perinatally have a unique risk of nonadherence in adolescence, as well as an elevated risk of mental health and substance use problems.&nbsp; 10:20 AM, Fri December 15, 2017 Stressed Out At Work? Ways to Cope with Challenges Here are some ways to cope with any stress or challenges that community pharmacy may bring. 4:46 AM, Wed November 29, 2017 What the WHO Essentials List Means for Mental Health One glaring omission is the lack of psychiatric medications included.<br /> &nbsp; 8:00 AM, Fri November 24, 2017 What Pharmacists Should Know About the Abilify MyCite Pill With the smart tablets coming to market in 2018, it is a good time to explore how the technology behind the product works. 2:34 AM, Fri November 17, 2017 10 Natural Remedies to Consider for Treating Anxiety Here is how to go beyond conventional medicine to help those who suffer from the leading mental health disorder in the United States. 12:06 AM, Thu October 26, 2017 5 Psychiatry Studies Pharmacists Should Know About Over the years, a number of landmark clinical studies in the field of psychiatry have been published, shaping how we treat mental illness. Here are 5 that every pharmacist should know about. 3:47 AM, Wed September 20, 2017 Pharmacists Can Play Important Role in Depression Screening According to the US Preventive Services Task Force&#39;s (USPSTF) updated recommendations for depression screening in adults, major depressive disorder is the leading cause of disability among adults in high-income countries. 3:10 PM, Sun September 3, 2017 What is the National Council on Patient Information and Education? Here is the 411 on this organization, which offers programs to help consumers better understand their medications. 11:36 PM, Wed August 23, 2017 Management of Psychosis in Parkinson's Disease: Clinical Tidbits What are the best practice considerations for managing Parkinson's Psychosis? 11:26 PM, Tue May 9, 2017 Carving Out a Niche in the Treatment of Tardive Dyskinesia The FDA recently approved Ingrezza (valbenazine) for the treatment of adults with tardive dyskinesia. 1:33 AM, Wed May 3, 2017